AR-V7 PROGRAM（AnHorn Medicines）

N/A

Report date: 2022/12/16 17:04:25
NME

Base Information

Drug NameAR-V7 PROGRAM（AnHorn Medicines）
Drug Alias NameN/A
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionAndrogen Receptor degraders
TargetsAndrogen Receptor
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnHorn Medicines Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnHorn Medicines Co Ltd
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A